<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2022.890709</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The Role of the Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger in Aberrant Intracellular Ca<sup>2+</sup> in Cardiomyocytes of Chagas-Infected Rodents</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lopez</surname>
<given-names>Jose R.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/604980"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Linares</surname>
<given-names>Nancy</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Adams</surname>
<given-names>Jose A.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/811815"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Mijares</surname>
<given-names>Alfredo</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1213337"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Research, Mount Sinai, Medical Center</institution>, <addr-line>Miami, FL</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Centro de Biof&#xed;sica y Bioqu&#xed;mica, Instituto Venezolano de Investigaciones Cient&#xed;ficas</institution>, <addr-line>Caracas</addr-line>, <country>Venezuela</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Division of Neonatology, Mount Sinai, Medical Center</institution>, <addr-line>Miami, FL</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Vilma G. Duschak, Consejo Nacional de Investigaciones Cient&#xed;ficas y T&#xe9;cnicas (CONICET), Argentina</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Veronica Jimenez, California State University, Fullerton, United States; Sergio Schenkman, Federal University of S&#xe3;o Paulo, Brazil</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Alfredo Mijares, <email xlink:href="mailto:mijaresa@gmail.com">mijaresa@gmail.com</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Parasite and Host, a section of the journal Frontiers in Cellular and Infection Microbiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>07</day>
<month>07</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>12</volume>
<elocation-id>890709</elocation-id>
<history>
<date date-type="received">
<day>06</day>
<month>03</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>06</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Lopez, Linares, Adams and Mijares</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Lopez, Linares, Adams and Mijares</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Chagas disease is produced by the parasite <italic>Trypanosoma cruzi (T. cruzi)</italic>, which is the leading cause of death and morbidity in Latin America. We have shown that in patients with Chagas cardiomyopathy, there is a chronic elevation of diastolic Ca<sup>2+</sup> concentration ([Ca<sup>2+</sup>]<sub>d</sub>), associated with deterioration to further address this issue, we explored the role Na<sup>+</sup>/Ca<sup>2+</sup> exchanger (NCX). Experiments were carried out in noninfected C57BL/6 mice and infected with blood-derived trypomastigotes of the <italic>T. cruzi</italic> Y strain. Anesthetized mice were sacrificed and the cardiomyocytes were enzymatically dissociated. Diastolic [Ca<sup>2+</sup>] ([Ca<sup>2+</sup>]<sub>d</sub>) was measured using Ca<sup>2+</sup> selective microelectrodes in cardiomyocytes from control mice (CONT) and cardiomyocytes from <italic>T. cruzi</italic> infected mice in the early acute phase (EAP) at 20 dpi, in the acute phase (AP) at 40 dpi, and in the chronic phase (CP) at 120 dpi. [Ca<sup>2+</sup>]<sub>d</sub> was 1.5-times higher in EAP, 2.6-times in AP, and 3.4-times in CP compared to CONT. Exploring the reverse mode activity of NCX, we replaced extracellular Na<sup>+</sup> in equivalent amounts with N-methyl-D-glucamine. Reduction of [Na<sup>+</sup>]<sub>e</sub> to 65 mM caused an increase in [Ca<sup>2+</sup>]<sub>d</sub> of 1.7 times in cardiomyocytes from CONT mice, 2 times in EAP infected mice, 2.4 times in AP infected mice and 2.8 in CP infected mice. The Na<sup>+</sup> free solution caused a further elevation of [Ca<sup>2+</sup>]<sub>d</sub> of 2.5 times in cardiomyocytes from CONT, 2.8 times in EAP infected mice, 3.1 times in AP infected mice, and 3.3 times in CP infected mice. Extracellular Ca<sup>2+</sup> withdrawal reduced [Ca<sup>2+</sup>]<sub>d</sub> in both CONT and cardiomyocytes from Chagas-infected mice and prevented the increase in [Ca<sup>2+</sup>]<sub>d</sub> induced by Na<sup>+</sup> depletion. Preincubation with 10&#xb5;M KB-R7943 or in 1&#xb5;M YM-244769 reduced [Ca<sup>2+</sup>]<sub>d</sub> in cardiomyocytes from infected mice, but not control mice. Furthermore, both NCX blockers prevented the increase in [Ca<sup>2+</sup>]<sub>d</sub> associated with exposure to a solution without Na<sup>+</sup>. These results suggest that Ca<sup>2+</sup> entry through the reverse NCX mode plays a significant role in the observed [Ca<sup>2+</sup>]<sub>d</sub> dyshomeostasis in Chagas infected cardiomyocytes. Additionally, NCX inhibitors may be a viable therapeutic approach for treating patients with Chagas cardiomyopathy.</p>
</abstract>
<kwd-group>
<kwd>chagas disease</kwd>
<kwd>Na/Ca exchanger</kwd>
<kwd>cardiomyopathy</kwd>
<kwd>
<italic>Trypanosoma cruzi</italic> (T cruzi)</kwd>
<kwd>calcium</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="44"/>
<page-count count="9"/>
<word-count count="5087"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Chagas disease, caused by the protozoan <italic>Trypanosoma cruzi</italic> (<italic>T. cruzi</italic>), affects approximately eight million people in the poorest areas of Central and South America. The prevalent form of transmission of <italic>T. cruzi</italic> to humans is contact with contaminated feces/urine of the invertebrate vector during a blood meal. However, human infection through blood transfusion, organ transplantation and oral. (<xref ref-type="bibr" rid="B7">Bern et&#xa0;al., 2008</xref>) and oral transmission due to ingestion of contaminated fruit juices (<xref ref-type="bibr" rid="B3">Alarcon De Noya et&#xa0;al., 2010</xref>) have been reported. Chagas disease is characterized by a varied clinical scenario that evolves from an acute phase, often asymptomatic or oligosymptomatic, to a chronic phase that can manifest as indeterminate, cardiac, or digestive forms (<xref ref-type="bibr" rid="B15">Echavarria et&#xa0;al., 2021</xref>). Most infected people develop cardiac conditions characterized by ventricular arrhythmias, heart blocks, heart failure, thromboembolic phenomena, and sudden death (<xref ref-type="bibr" rid="B34">Rassi et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B39">Teixeira et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B15">Echavarria et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B21">http://www.who.int/mediacentre/factsheets/fs340/en/, 2021</xref>).</p>
<p>Calcium is a central player in the regulation of cardiac contractility, and its intracellular concentration is maintained through the interaction of Ca<sup>2+</sup> transport mechanisms and diastolic leak mediated by the ryanodine receptor (<xref ref-type="bibr" rid="B36">Shannon et&#xa0;al., 2003</xref>; <xref ref-type="bibr" rid="B13">Bers and Ginsburg, 2007</xref>; <xref ref-type="bibr" rid="B10">Bers, 2014</xref>; <xref ref-type="bibr" rid="B18">Freichel et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B37">Smith and Eisner, 2019</xref>). In healthy cardiomyocytes, the diastolic Ca<sup>2+</sup> concentration ([Ca<sup>2+</sup>]<sub>d</sub>) is in the range of 100-120 nM (<xref ref-type="bibr" rid="B29">Marban et&#xa0;al., 1980</xref>; <xref ref-type="bibr" rid="B27">Lopez et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B30">Mijares et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B31">Mijares et&#xa0;al., 2020</xref>). We have demonstrated dysregulation of [Ca<sup>2+</sup>]<sub>d</sub> in cardiomyocytes isolated from Chagas patients, which is correlated with the patient&#x2019;s clinical condition (<xref ref-type="bibr" rid="B27">Lopez et&#xa0;al., 2011</xref>). Furthermore, this diastolic disturbance of [Ca<sup>2+</sup>] appears to be associated with alterations in the regulation of the intracellular messenger inositol 1,4,5-trisphosphate (<xref ref-type="bibr" rid="B27">Lopez et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B31">Mijares et&#xa0;al., 2020</xref>).</p>
<p>NCX is a bidirectional high-capacity transporter that represents the primary way of Ca<sup>2+</sup> extrusion in excitable cells (<xref ref-type="bibr" rid="B14">Blaustein and Lederer, 1999</xref>; <xref ref-type="bibr" rid="B5">Aronsen et&#xa0;al., 2013</xref>). It can import 3 Na<sup>+</sup> into the cell in exchange for 1 Ca<sup>2+</sup> (forward mode) or drive the efflux of 3 Na<sup>+</sup> in exchange for 1 Ca<sup>2+</sup> (reverse mode) across the plasma membrane (<xref ref-type="bibr" rid="B13">Bers and Ginsburg, 2007</xref>). The direction of NCX (forward or reverse) depends on the internal and external concentration of both Na<sup>+</sup> and Ca<sup>2+</sup> and the membrane potential (<xref ref-type="bibr" rid="B8">Bers, 2000</xref>). NCX works almost exclusively in the forward mode (Ca<sup>2+</sup> extrusion) in normal cardiomyocytes, driven primarily by the elevated subsarcolemmal [Ca<sup>2+</sup>]. Elevated diastolic [Na<sup>+</sup>] ([Na<sup>+</sup>]<sub>d</sub>) could change the direction of the fluxes to a more significant influx of Ca<sup>2 +</sup> and fewer Ca<sup>2 +</sup> effluxes, resulting in increased intracellular [Ca<sup>2+</sup>]. However, the dynamic of NCX can be altered in pathophysiological situations such as heart failure, arrhythmia, ischemia-reperfusion injury, and hypertrophy (<xref ref-type="bibr" rid="B12">Bers and Despa, 2006</xref>). Recently, Santos-Miranda et&#xa0;al. (<xref ref-type="bibr" rid="B35">Santos-Miranda et&#xa0;al., 2021</xref>) reported a cellular arrhythmogenic profile in chronic Chagas cardiomyopathy, which was sensitive to Ni<sup>2+</sup> and NCX blocker SEA0400, indicating the involvement of NCX.</p>
<p>In the present study, we evaluated the activity of NCX in cardiomyocytes from control and Chagas infected mice. We showed that NCX activity is enhanced in cardiomyocytes from <italic>T. cruzi-</italic>infected mice compared to control cardiomyocytes and that the reverse mode of NCX contributes to intracellular Ca<sup>2 +</sup> dyshomeostasis observed in cardiomyocytes from infected mice.</p>
</sec>
<sec id="s2">
<title>Material and Methods</title>
<sec id="s2_1">
<title>Animals</title>
<p>Homozygous male C57BL/10 with a bodyweight of 25 &#xb1; 0.45 g. and 12 weeks of age were housed at constant temperature (24 C) and a 12 h light/12 h dark cycle, with free access to water and fed a commercial pelletized diet.</p>
</sec>
<sec id="s2_2">
<title>
<italic>Trypanosoma cruzi</italic> Infection</title>
<p>Mice were randomly divided into two groups: <bold>Group A</bold> (Control) that were not inoculated with <italic>T. cruzi</italic> and <bold>Group B</bold> (infected mice) were infected intraperitoneally with 5x10<sup>-2</sup> blood-form trypomastigotes of the Y strain of <italic>T. cruzi</italic> (<xref ref-type="bibr" rid="B32">O&#x2019;Daly et&#xa0;al., 1984</xref>). The Y strain of <italic>T. cruzi</italic> was originally obtained from patients in Brazil and was kindly provided by Dr. Jose O&#x2019;Daly, who has maintained the strain over the years through serial passages in homozygous C57B1/6 mice. Parasitemia was monitored by counting the number of parasites/5 &#x3bc;l of blood obtained from the tail vein of infected mice. A positive parasitemia was found in all inoculated animals on days 12-15 post-infection (dpi). Non-infected and infected anesthetized (ketamine/xylazine) mice were sacrificed by cervical dislocation at 20 (early acute phase), 40 (acute phase), and 120-dpi (chronic phase), and the cardiomyocytes were enzymatically dissociated.</p>
</sec>
<sec id="s2_3">
<title>Isolation of Cardiomyocytes and Inclusion Criteria</title>
<p>Control and infected mice were anesthetized (ketamine 100 mg/kg/xylazine 5 mg/Kg) and hearts were rapidly removed, attached to a cannula, and mounted on a Langendorff reverse coronary perfusion system for the enzymatic dissociation of ventricular cardiomyocytes (<xref ref-type="bibr" rid="B24">Liao and Jain, 2007</xref>). Only Ca<sup>2+</sup> tolerant cardiomyocytes with rod-shaped, well-defined striation spacing and a resting sarcomere length of &#x2265;1.75 &#xb5;m (<xref ref-type="bibr" rid="B44">Wussling et&#xa0;al., 1987</xref>) were used and studied within 4-6 h after isolation. The isolation procedure was carried out at 37&#xb0;C.</p>
</sec>
<sec id="s2_4">
<title>Ca<sup>2+</sup> and Na<sup>+</sup> Selective Microelectrodes</title>
<p>Double-barreled Ca<sup>2+</sup> and Na<sup>+</sup> selective microelectrodes were prepared as previously described (<xref ref-type="bibr" rid="B16">Eltit et&#xa0;al., 2013</xref>). Each ion-selective microelectrode was individually calibrated before and after the determination of [Ca<sup>2+</sup>]<sub>d</sub> and the [Na<sup>+</sup>]<sub>d</sub> as previously described (<xref ref-type="bibr" rid="B30">Mijares et&#xa0;al., 2014</xref>). Ca<sup>2+</sup> selective microelectrodes with a Nernstian response between pCa3 and pCa7 (30.5 mV/pCa units at 37&#xb0;C) and Na<sup>+</sup> selective microelectrodes with Nernstian responses between 100 and 10 mM [Na<sup>+</sup>]<sub>e</sub>, and an adequate response (40&#x2013;45 mV) between 10 and 1 mM [Na<sup>+</sup>]<sub>e</sub> were used experimentally (<xref ref-type="bibr" rid="B25">Lopez et&#xa0;al., 1983</xref>; <xref ref-type="bibr" rid="B26">Lopez et&#xa0;al., 2000</xref>; <xref ref-type="bibr" rid="B16">Eltit et&#xa0;al., 2013</xref>). The Ca<sup>2+</sup>- and Na<sup>+</sup>-microelectrode response was not affected by any of the drugs used in the present study.</p>
</sec>
<sec id="s2_5">
<title>Recording of Diastolic Calcium and Sodium Concentrations</title>
<p>Isolated cardiomyocytes from control mice and <italic>T. cruzi</italic> infected mice were impaled with double-barrel Ca<sup>2+</sup> or Na<sup>+</sup> microelectrodes to measure [Ca<sup>2+</sup>]<sub>d</sub> and [Na<sup>+</sup>]<sub>d</sub>, respectively, and potentials were recorded using a high impedance electrometer (WPI 773 electrometer, FL, USA) as previously described (<xref ref-type="bibr" rid="B26">Lopez et&#xa0;al., 2000</xref>; <xref ref-type="bibr" rid="B28">Lopez et&#xa0;al., 2017</xref>). The potential of the 3M KCl microelectrode barrel (Vm) was electronically subtracted from the potential recorded by the Ca<sup>2+</sup> selective barrel (V<sub>Ca</sub>) to produce a differential Ca<sup>2+</sup> specific potential (V<sub>CaE</sub>) that represents the cardiomyocyte [Ca<sup>2+</sup>]<sub>d</sub>. A similar approach was used to produce the specific Na<sup>+</sup> potential (V<sub>NaE</sub>), which represents the cardiomyocyte [Na<sup>+</sup>]<sub>d</sub>. The potentials were acquired at a frequency of 1,000 Hz with the AxoGraph software (version 4.6; Axon Instruments, CA, USA) and stored in a computer for further analysis.</p>
<p>Individual cardiomyocyte measurements of [Ca<sup>2+</sup>]<sub>d</sub> and [Na<sup>+</sup>]<sub>d</sub> from control and infected mice were accepted when there was <bold>
<italic>i)</italic>
</bold> an abrupt drop to a steady level of Vm equal to or more negative than -80 mV in healthy cells and -70 mV in unhealthy cardiomyocytes; <bold>
<italic>ii)</italic>
</bold> a stable recording of Vm and V<sub>Ca</sub> potentials or Vm and V<sub>Na</sub> potentials for more than 60 seconds and an abrupt return to baseline at the exit of the microelectrode from the cell. Vm was used as a biological indicator of the integrity of cardiomyocyte sarcolemma in real-time; therefore, any cardiomyocytes with a recorded Vm &lt;-70 mV were discarded. These criteria were not met in 18% of total impalements performed in cardiomyocytes from control mice and 41% in infected mouse cardiomyocytes.</p>
</sec>
<sec id="s2_6">
<title>Reverse Mode NCX Protocol</title>
<p>The effect of NCX (reverse mode) on [Ca<sup>2+</sup>]<sub>d</sub> in cardiomyocytes from control and infected mice was determined by preincubating cardiomyocytes in a solution in which [Na<sup>+</sup>]e was partially or completely removed (see solutions below) and replaced by <italic>N</italic>-methyl-<sc>d</sc>-glucamine hydrochloride. Measurements of [Ca<sup>2+</sup>]<sub>d</sub> were carried out before and after incubation in low Na<sup>+</sup> solutions.</p>
</sec>
<sec id="s2_7">
<title>Equilibrium Potentials</title>
<p>The equilibrium potentials for Ca<sup>2+</sup> (<italic>E</italic>
<sub>Ca</sub>) and Na<sup>+</sup> (<italic>E</italic>
<sub>Na</sub>) were calculated using the Nernst equation (<italic>E<sub>ion</sub>=</italic> RT/zF x ln [ion]<sub>i/</sub>[ion]<sub>e</sub>) and [Ca<sup>2+</sup>]<sub>d</sub> and [Na<sup>+</sup>]<sub>d</sub> obtained in cardiomyocytes from CONT and infected mice in EAP, AP, and CP. The equilibrium potential of the Na<sup>+</sup>/Ca<sup>2+</sup> exchanger (<italic>E</italic>
<sub>NCX</sub>) was estimated using the following equation: <italic>E<sub>NCX</sub>
</italic> = 3E<sub>Na</sub> - 2E<sub>Ca</sub> (with a stoichiometry of 3:1), where <italic>E</italic>
<sub>Na</sub> and <italic>E</italic>
<sub>Ca</sub> are the equilibrium potentials of Na<sup>+</sup> and Ca<sup>2+</sup> obtained from the Nernst equation.</p>
</sec>
<sec id="s2_8">
<title>Solutions</title>
<p>All solutions were made with ultrapure water supplied by a Milli-Q system (Millipore, Bedford, MA). The Tyrode solution had the following composition (in mM): 130 NaCl, 5 KCl, 2.5 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>, 20 NaHCO<sub>3</sub>, 0.33 NaH<sub>2</sub>PO<sub>4</sub>, and 10 glucose gassed with 95% O<sub>2</sub> and 5% CO<sub>2</sub>, pH 7.4. A low- or Na<sup>+</sup>-free solution was prepared by the partial or total withdrawal of [Na<sup>+</sup>]<sub>e</sub>, and replacement by an equivalent amount of impermeable cation <italic>N</italic>-methyl-<sc>d</sc>-glucamine (NMG) hydrochloride to maintain osmolarity. A Ca<sup>2 +</sup>-free solution was prepared, omitting CaCl<sub>2</sub> and adding 1 m<sc>m</sc> of EGTA and 2 m<sc>m</sc> of MgCl<sub>2</sub>. Solutions 2-(2-(4-(4-nitrobenzyloxy-phenyl-ethyl-isothiourea methanesulfonate (KB-R7943) and N- (3-aminobenzyl) -6- 4- [(3-fluorobenzyl-oxy] phenoxy nicotinamide (YM-244769) were made by adding the desired concentration of the reagent to the Tyrode solution. All experiments were carried out at 37&#xb0;C.</p>
</sec>
<sec id="s2_9">
<title>Statistical Analysis</title>
<p>Experimental results are expressed as means &#xb1; SD; <italic>n<sub>mice</sub>
</italic> represents the number of mice used and <italic>n<sub>cells</sub>
</italic> the number of successful measurements in cardiomyocytes isolated from CONT and infected mice used for statistical analysis. Data were analyzed using one-way analysis of variance ANOVA for repeated measures, followed by Tukey&#x2019;s multiple comparison tests to determine significance. A <italic>p</italic>&lt;0.05 was considered significant. GraphPad Prism 9 (GraphPad Software, CA, USA) was used for statistical analysis.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>[Ca<sup>2+</sup>]<sub>d</sub> and [Na<sup>+</sup>]<sub>d</sub> in Ventricular Cardiomyocytes of Chagasic Rodents</title>
<p>We previously reported a significant elevation in [Ca<sup>2+</sup>]<sub>d</sub> in cardiomyocytes obtained from patients with chronic Chagas cardiomyopath, which was related to the extent of their cardiac dysfunction (<xref ref-type="bibr" rid="B27">Lopez et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B31">Mijares et&#xa0;al., 2020</xref>). <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref> shows representative records of simultaneous measurement of Vm and [Ca<sup>2+</sup>]<sub>d</sub> in a single cardiomyocyte isolated from (<bold>A</bold>) CONT mice, (<bold>B</bold>) EAP-infected mice (20 dpi), (<bold>C</bold>) AP-infected mice (40 dpi), and (<bold>D</bold>) CP-infected mice (120 dpi). The cardiomyocytes of Chagas-infected mice showed partial depolarization and increased [Ca<sup>2+</sup>]<sub>d</sub>, which aggravated as a function of days after infection. The mean Vm and [Ca<sup>2+</sup>]<sub>d</sub> in quiescent cardiomyocytes from CONT mice were 81 &#xb1; 1 mV and 122 &#xb1; 3 nM. Respectively. In cardiomyocytes from EAP-infected mice, Vm was 78 &#xb1; 1.7 mV and [Ca<sup>2+</sup>]<sub>d</sub> 194 &#xb1; 23 nM (<italic>p</italic>&lt;0.001 compared to CONT cardiomyocytes); in cardiomyocytes from AP-infected mice, Vm was 76 &#xb1; 1.6 mV and [Ca<sup>2+</sup>]<sub>d</sub> 320 &#xb1; 38 nM (<italic>p</italic>&lt;0.001 compared to CONT cardiomyocytes) and in cardiomyocytes from CP-infected mice, Vm was 72 &#xb1; 1.8 mV and [Ca<sup>2+</sup>]<sub>d</sub> 470 &#xb1; 43 nM (<italic>p</italic>&lt;0.001 compared to CONT cardiomyocytes) (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2A, B</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Representative measurements of Vm and [Ca<sup>2+</sup>]<sub>d</sub> in cardiomyocytes from control and Chagas infected mice. Simultaneous measurements of membrane potential (Vm) and [Ca<sup>2+</sup>]<sub>d</sub> <bold>(A)</bold> Cardiomyocyte from control mice (Vm was -82 mV and [Ca<sup>2+</sup>]<sub>d</sub> 122 nM). <bold>(B)</bold> Cardiomyocyte from EAP-infected mice (Vm was -76mV and [Ca<sup>2+</sup>]<sub>d</sub> 200 nM). <bold>(C)</bold> Cardiomyocyte from AP-infected mice (Vm was -73 mV and [Ca<sup>2+</sup>]<sub>d</sub> 312 nM). <bold>(D)</bold> Cardiomyocyte from CP-infected mice (Vm was -69 mV and [Ca<sup>2+</sup>]<sub>d</sub> 414 nM). Vm, resting membrane potential and V<sub>Cae</sub>, specific calcium potential; CONT, control mice; EAP, infected mice in the early acute phase; AP, infected mice in the acute phase; and CP, infected mice in the chronic phase. Calibration bar = 1 minute.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-890709-g001.tif"/>
</fig>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Resting membrane potential, diastolic [Ca<sup>2+</sup>] and [Na<sup>+</sup>] in cardiomyocytes from control and Chagas infected mice. <bold>(A)</bold> The resting membrane potential, <bold>(B)</bold> [Ca<sup>2+</sup>]<sub>d,</sub> and <bold>(C)</bold> [Na<sup>+</sup>]<sub>d</sub> were measured in quiescent cardiomyocytes from CONT mice (<italic>n<sub>cells</sub>
</italic>=24 and <italic>n<sub>mice</sub>
</italic>=3), EAP-infected mice (<italic>n<sub>cells</sub>
</italic>=19 and <italic>n<sub>mice</sub>
</italic>=3), AP-infected mice (<italic>n<sub>cells</sub>
</italic>=21 and <italic>n<sub>mice</sub>
</italic>=3) and CP-infected mice (<italic>n<sub>cells</sub>
</italic>=18 and <italic>n<sub>mice</sub>
</italic>=5). Data are expressed as means &#xb1; S.D. Statistical analysis was performed using one-way ANOVA, followed by Tukey&#x2019;s multiple comparison tests, *<italic>p</italic> &lt; 0.05; ***<italic>p</italic> &lt; 0.001. CONT, control mice; EAP, early acute phase of infected mice; AP, acute phase of infected mice; and CP, chronic phase of infected mice.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-890709-g002.tif"/>
</fig>
<p>Similar differences in [Na<sup>+</sup>]<sub>d</sub> were obtained in the measurements carried out in quiescent cardiomyocytes of Chagas-infected mice at different phases of infection. In cardiomyocytes from CONT mice [Na<sup>+</sup>]<sub>d</sub> was 8 &#xb1; 0.2 mM; In cardiomyocytes from EAP-infected mice [Na<sup>+</sup>]<sub>d</sub> was 9.4 &#xb1; 0.7 mM (<italic>p</italic>&lt;0.001 compared to CONT cardiomyocytes); In cardiomyocytes from AP-infected mice [Na<sup>+</sup>]<sub>d</sub> was 13.9 &#xb1; 0.8 mM (<italic>p</italic>&lt;0.001 compared to CONT cardiomyocytes); and in cardiomyocytes from CP-infected mice [Na<sup>+</sup>]<sub>d</sub> was 15.9 &#xb1; 1 mM (<italic>p</italic>&lt;0.001 compared to CONT cardiomyocytes) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>).</p>
</sec>
<sec id="s3_2">
<title>Removal of [Na<sup>+</sup>]<sub>e</sub> Increased [Ca<sup>2+</sup>]<sub>d</sub> in Cardiomyocytes</title>
<p>In a separate set of experiments, the reverse mode activity of NCX (Ca<sup>2+</sup> entry in exchange for Na<sup>+</sup> leaving the cell) was studied in quiescent cardiomyocytes isolated from control and infected mice by incubation in a solution in which Na<sup>+</sup> was replaced in equivalent amounts by NMG. [Ca<sup>2+</sup>]<sub>d</sub> was measured before and after incubation with a low or Na<sup>+</sup> free solution. The reduction of [Na<sup>+</sup>]<sub>e</sub> to 65 mM caused an increase in [Ca<sup>2+</sup>]<sub>d</sub> in CONT cardiomyocytes to 212 &#xb1; 27 n<sc>m,</sc> in cardiomyocytes from EAP-infected mice to 400 &#xb1; 24 nM, in cardiomyocytes from AP infected mice to 790 &#xb1; 62 nM, and cardiomyocytes from CP-infected mice to 1,320 &#xb1; 137 nM (<italic>p</italic>&lt;0.001 compared to cardiomyocytes from CONT, EAP, AP and CP-infected mice bathed in normal [Na<sup>+</sup>]<sub>e</sub>) (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Effects of reduction in [Na<sup>+</sup>]<sub>e</sub> on [Ca<sup>2+</sup>]<sub>d</sub> in cardiomyocytes from control and Chagas infected mice. [Ca<sup>2+</sup>]<sub>d</sub> was measured before and after cardiomyocyte treatments with solutions in which [Na<sup>+</sup>]<sub>e</sub> was partially or completely replaced with NMG. [Ca<sup>2+</sup>]<sub>d</sub> was determined in quiescent cardiomyocytes from CONT mice (<italic>n<sub>cells</sub>
</italic>=13-24 and <italic>n<sub>mice</sub>
</italic>=4), EAP-infected mice (<italic>n<sub>cells</sub>
</italic>=12-19 and <italic>n<sub>mice</sub>
</italic>=5), AP-infected mice (<italic>n<sub>cells</sub>
</italic>=12-21 and <italic>n<sub>mice</sub>
</italic>=5) and CP-infected mice (<italic>n<sub>cells</sub>
</italic>=6-18 and <italic>n<sub>mice</sub>
</italic>=9). Data are expressed as means &#xb1; S.D. Statistical analysis was performed as described above, ***<italic>p</italic> &lt; 0.001. CONT, control mice; EAP, early acute phase of infected mice; AP, acute phase of infected mice; and CP, chronic phase of infected mice.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-890709-g003.tif"/>
</fig>
<p>Incubation in Na<sup>+</sup> free solution caused a further increase in [Ca<sup>2+</sup>]<sub>d</sub> in control and cardiomyocytes from infected mice. In CONT cardiomyocytes [Ca<sup>2+</sup>]<sub>d</sub> increased significantly to 309 &#xb1; 42 nM, in cardiomyocytes from EAP-infected mice to 540 &#xb1; 69 nM, from AP-infected mice to 1,016 &#xb1; 64 nM, and from CP-infected mice to 1,523 &#xb1; 62 nM respectively (<italic>p</italic>&lt;0.001 compared to cardiomyocytes from CONT, and EAP-, AP- and CP- infected mice bathed in normal [Na<sup>+</sup>]<sub>e</sub>). (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>). The sustained increase [Ca<sup>2+</sup>]<sub>d</sub> was maintained as long as Na<sup>+</sup> was absent from the bath solution and reversed when Na<sup>+</sup> was reintroduced into the Tyrode solution, except for cardiomyocytes from CP- infected mice where an irreversible elevation [Ca<sup>2+</sup>]<sub>d</sub> associated with contracture was observed.</p>
</sec>
<sec id="s3_3">
<title>Removal of Extracellular Ca<sup>2+</sup> Prevents the Increase in [Ca<sup>2+</sup>]<sub>d</sub> Induced by Na<sup>+</sup> Depletion</title>
<p>In a different set of experiments, we explored the contribution of the Ca<sup>2+</sup> influx to the elevation of [Ca<sup>2+</sup>]<sub>d</sub> elicited by the withdrawal of Na<sup>+</sup> in quiescent cardiomyocytes from control and infected mice. Cardiomyocytes were incubated for 10 minutes in a Ca<sup>2+</sup>-free solution prior to the withdrawal of Na<sup>+</sup> (see solutions). Incubation in a Ca<sup>2+</sup>-free solution significantly reduced [Ca<sup>2+</sup>]<sub>d</sub> to 98 &#xb1; 5 nM in cardiomyocytes from CONT mice (<italic>p</italic>&lt;0.001 compared to CONT cardiomyocytes in normal [Ca<sup>2+</sup>]<sub>e</sub>), to 100 &#xb1; 11 nM in cardiomyocytes from EAP-infected mice (<italic>p</italic>&lt;0.001 compared to EAP cardiomyocytes in normal [Ca<sup>2+</sup>]<sub>e</sub>), to 123 &#xb1; 14 nM cardiomyocytes from AP-infected mice (<italic>p</italic>&lt;0.001 compared to AP cardiomyocytes in normal [Ca<sup>2+</sup>]<sub>e</sub>), and to 136 &#xb1; 11 nM in cardiomyocytes from CP-infected mice (<italic>p</italic>&lt;0.001 compared to CP cardiomyocytes in normal [Ca<sup>2+</sup>]<sub>e</sub>). (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>). Elevation of [Ca<sup>2+</sup>]<sub>d</sub> induced by withdrawal of Na<sup>+</sup> was abolished in the absence of extracellular Ca<sup>2+</sup> in all cardiomyocyte groups (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Effect extracellular Ca<sup>2+</sup> on Na<sup>+</sup> depletion-induced elevation of [Ca<sup>2+</sup>]<sub>d</sub>. [Ca<sup>2+</sup>]<sub>d</sub> was measured in cardiomyocytes from CONT, EAP-, AP-, and CP-infected mice in normal Tyrode, Ca<sup>2+</sup>-free Tyrode solution, and Ca<sup>2+</sup> and Na<sup>+</sup> free Tyrode solution. [Ca<sup>2+</sup>]<sub>d</sub> was determined in quiescent cardiomyocytes from CONT (<italic>n<sub>cells</sub>
</italic>=16-24 and <italic>n<sub>mice</sub>
</italic>=4), EAP-infect mice (<italic>n<sub>cells</sub>
</italic>=15-19 and <italic>n<sub>mice</sub>
</italic>=5), AP-infect mice (<italic>n<sub>cells</sub>
</italic>=18-21 and <italic>n<sub>mice</sub>
</italic>=6) and CP-infect mice (<italic>n<sub>cells</sub>
</italic>=15-18 and <italic>n<sub>mice</sub>
</italic>=8). Data are expressed as mean &#xb1; S.E. Statistical analysis was performed as described above, *** <italic>p</italic> &lt; 0.001. CONT, control mice; EAP, early acute phase of infected mice; AP, acute phase of infected mice; and CP, chronic phase of infected mice. ns, no significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-890709-g004.tif"/>
</fig>
</sec>
<sec id="s3_4">
<title>Equilibrium Potentials</title>
<p>Using the Nernst equation and the actual values [Ca<sup>2+</sup>]<sub>d</sub> and [Na<sup>+</sup>]<sub>d</sub> found in the present study, the estimated <italic>E</italic>
<sub>Ca</sub> in cardiomyocytes from CONT mice was +133 mV, in cardiomyocytes from EAP-infected mice was +127 mV, in cardiomyocytes from AP-infected mice was +119 mV, and in cardiomyocytes from CP-infected mice were +116 mV. While the estimated <italic>E</italic>
<sub>Na</sub> in cardiomyocytes isolated from CONT mice was +74 mV, EAP-infected mice was +70 mV, AP-infected mice was +59 mV, and CP-infected mice was +56 mV. The equilibrium potential of the Na<sup>+</sup>/Ca<sup>2+</sup> exchanger (<italic>E</italic>
<sub>NCX</sub>) was -44 mV in cardiomyocytes from CONT, -46 mV from EA-infected mice, -61 mV from AP-infected mice, and &#x2013;64 mV from CP-infected mice, respectively.</p>
</sec>
<sec id="s3_5">
<title>KB-R7943 and YM-244769 Reduced [Ca<sup>2+</sup>]<sub>d</sub> and Prevented the Elevation of Ca<sup>2+</sup> Induced by the Na<sup>+</sup> Free Solution</title>
<p>To determine the mechanisms involved in the elevation of [Ca<sup>2+</sup>]<sub>d</sub> caused by exposure to Na<sup>+</sup> free medium, quiescent cardiomyocytes from control and infected mice were incubated in KB-R7943, a nonspecific blocker of the NCX reverse mode, which modified Na<sup>+</sup> dependent binding (<xref ref-type="bibr" rid="B23">Iwamoto et&#xa0;al., 1996</xref>; <xref ref-type="bibr" rid="B2">Akabas, 2004</xref>). Cardiomyocyte preincubation with 10 &#x3bc;<sc>m</sc> KB-R7943 for 10 minutes significantly reduced [Ca<sup>2+</sup>]<sub>d</sub> and inhibited the increase in [Ca<sup>2+</sup>]<sub>d</sub> induced by the solution without Na<sup>+</sup> (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). KB-R7943 reduced [Ca<sup>2+</sup>]<sub>d</sub> to 152 &#xb1; 16 nM in cardiomyocytes from EAP-infected mice, to 186 &#xb1; 21 nM from AP-infected mice, and 258 &#xb1; 30 nM from CP-infected mice (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). No significant effect was observed in cardiomyocytes from CONT mice (116 &#xb1; 5 nM<italic>).</italic> Preincubation with KB-R7943 prevented the elevation of [Ca<sup>2+</sup>]<sub>d</sub> caused by the Na<sup>+</sup> free solution in cardiomyocytes of control and infected mice (compare <xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3</bold>
</xref>,<xref ref-type="fig" rid="f3">
<bold>5A</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>NCX blockers inhibited Na<sup>+</sup> withdraw-induced [Ca<sup>2+</sup>]<sub>d</sub> increases in cardiomyocytes from control and Chagas infected mice. <bold>(A)</bold> Effects of KB-R7943 and <bold>(B)</bold> YM-244769 on [Ca<sup>2+</sup>]<sub>d</sub> increases caused by Na<sup>+</sup> removal. [Ca<sup>2+</sup>]<sub>d</sub> was determined in (i) normal Tyrode solution (ii) after 10 min of incubation with 10 &#x3bc;m KB-R7943) or 1 &#xb5;M YM-244769 and (iii) after incubation, either KB-R7943 in Na<sup>+</sup> free solution or YM-244769 in Na<sup>+</sup> free solution. Experiments were carried out in cardiomyocytes from CONT (n<sub>cells</sub>=15-24 and n<sub>mice</sub>=6), EAP (n<sub>cells</sub>=12-19 and n<sub>mice</sub>=8), AP (n<sub>cells</sub>=13-21 and n<sub>mice</sub>=8) and CP cardiomyocytes (n<sub>cells</sub>=11-18 and n<sub>mice</sub>=9). Data are expressed as mean &#xb1; S.E. Statistical analysis was performed as described above, ***p &lt; 0.001. CONT: control mice; EAP: early acute phase of infected mice; AP: acute phase of infected mice; and CP: chronic phase of infected mice.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-890709-g005.tif"/>
</fig>
<p>Due to the lack of specificity of KB-R7943 (<xref ref-type="bibr" rid="B1">Abramochkin and Vornanen, 2014</xref>), we also examined the effects of YM-244769, a high-affinity blocker of the NCX reverse mode (<xref ref-type="bibr" rid="B22">Iwamoto and Kita, 2006</xref>). Incubation with 1 &#x3bc;<sc>m</sc> YM-244769 for 10 minutes reduced [Ca<sup>2+</sup>]<sub>d</sub> to 176 &#xb1; 20 nM in cardiomyocytes from EAP-infected mice, to 254 &#xb1; 19 nM from AP-infected mice, and to 336 &#xb1; 32 nM from CP-infected mice. YM-244769 did not significantly reduce [Ca<sup>2+</sup>]<sub>d</sub> in cardiomyocytes of CONT and EAP-infected mice. YM-244769 fully inhibited the elevation of [Ca<sup>2+</sup>]<sub>d</sub> induced by the Na<sup>+</sup> free solution in CONT cardiomyocytes and infected mice (compare <xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3</bold>
</xref>, <xref ref-type="fig" rid="f5">
<bold>5B</bold>
</xref>).</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Cardiac alterations are a severe and recurrent complication related to Chagas disease and represent the most common causes of heart failure and sudden death in Latin America (<xref ref-type="bibr" rid="B42">Velasco and Morillo, 2020</xref>). The present study reinforces our previous finding that progressive deterioration of cardiac function in Chagas cardiomyopathy is associated with defective intracellular Ca<sup>2+</sup> regulation. In this report, we demonstrate, for the first time, that ventricular cardiomyocytes from rodents infected with <italic>T. cruzi</italic> show a partial depolarization associated with aberrant [Ca<sup>2+</sup>]<sub>d</sub> and [Na<sup>+</sup>]<sub>d</sub>, which aggravated with endpoint after infection (chronic&gt;acute&gt;early acute). Furthermore, we provide evidence that chagasic infection enhances the reverse mode of NCX, causing an elevation of [Ca<sup>2+</sup>]<sub>d,</sub> which is not mediated by membrane depolarization.</p>
<p>Calcium is essential in the regulation of cardiac contractility, and defective intracellular Ca<sup>2+</sup> homeostasis plays an vital role in the pathogenesis of diverse cardiac diseases (<xref ref-type="bibr" rid="B20">Houser and Margulies, 2003</xref>; <xref ref-type="bibr" rid="B27">Lopez et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B40">Uryash et&#xa0;al., 2021a</xref>; <xref ref-type="bibr" rid="B41">Uryash et&#xa0;al., 2021b</xref>). [Ca<sup>2+</sup>]<sub>d</sub> is regulated by several mechanisms that controls Ca<sup>2+</sup> influx-efflux and intracellular reuptake that allow the maintenance of [Ca<sup>2+</sup>] within a physiological range (~100 nM) (<xref ref-type="bibr" rid="B27">Lopez et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B30">Mijares et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B31">Mijares et&#xa0;al., 2020</xref>). The [Ca<sup>2+</sup>]<sub>d</sub> values obtained from CONT cardiomyocytes are in agreement with previous estimates obtained from humans (<xref ref-type="bibr" rid="B27">Lopez et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B31">Mijares et&#xa0;al., 2020</xref>) and non-human ventricular myocytes (<xref ref-type="bibr" rid="B30">Mijares et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B40">Uryash et&#xa0;al., 2021a</xref>; <xref ref-type="bibr" rid="B41">Uryash et&#xa0;al., 2021b</xref>) using Ca<sup>2+</sup>-selective microelectrodes and fluorescent Ca<sup>2+</sup> indicator (<xref ref-type="bibr" rid="B33">Piacentino et&#xa0;al., 2003</xref>). The abnormal [Ca<sup>2+</sup>]<sub>d</sub> in cardiomyocytes from infected mice (chronic&gt;acute&gt;early acute) agree with a similar dysfunction observed in cardiomyocytes obtained from Chagas patients and could potentially promote arrhythmias, similar to those observed in patients with Chagas cardiomyopathy (<xref ref-type="bibr" rid="B6">Benziger et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B4">Almeida et&#xa0;al., 2018</xref>).</p>
<p>Normal resting [Na<sup>+</sup>]<sub>d</sub> in cardiomyocytes is in the range of 7-8 mM (<xref ref-type="bibr" rid="B19">Gray et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B30">Mijares et&#xa0;al., 2014</xref>), while in cardiomyocytes from infected mice, it was higher (CP&gt;EP&gt;AEP). Intracellular [Na<sup>+</sup>] is mainly regulated in cardiac myocytes by Na<sup>+</sup>/K<sup>+</sup>-ATPase, Na<sup>+</sup>/Ca<sup>2+</sup> exchange, Na<sup>+</sup> channels, and amiloride-sensitive Na<sup>+</sup>/H<sup>+</sup> exchanger (<xref ref-type="bibr" rid="B17">Everts et&#xa0;al., 1992</xref>; <xref ref-type="bibr" rid="B14">Blaustein and Lederer, 1999</xref>; <xref ref-type="bibr" rid="B11">Bers et&#xa0;al., 2003</xref>). An elevated [Na<sup>+</sup>]<sub>d</sub>, as found in Chagas-infected mice cardiomyocytes, could change the balance of fluxes through NCX to favor a greater inflow of Ca<sup>2+</sup> (reverse mode) (<xref ref-type="bibr" rid="B14">Blaustein and Lederer, 1999</xref>), contributing to intracellular Ca<sup>2+</sup> overload as observed in Chagas-infected mice cardiomyocytes. Furthermore, it is plausible that the partial depolarization observed in cardiomyocytes from infected mice (chronic&gt;acute&gt;early acute) may be related to diastolic Na<sup>+</sup> overload. Unfortunately, we did not explore whether the elevation of [Na<sup>+</sup>]<sub>d</sub> in cardiomyocytes from infected mice was related to an increased influx or decreased efflux of Na<sup>+</sup>; therefore, no conclusions can be drawn.</p>
  <p>Sodium-calcium exchange is the major Ca<sup>2+</sup> efflux mechanism of ventricular cardiomyocytes. NCX mediates an electrogenic exchange of 3 Na<sup>+</sup> for 1 Ca<sup>2+</sup>, which can occur in the forward (Ca<sup>2+</sup> extrusion&#x2013;Na<sup>+</sup> entry) or in the reverse (Ca<sup>2+</sup> entry&#x2013; Na<sup>+</sup> extrusion) mode (<xref ref-type="bibr" rid="B14">Blaustein and Lederer, 1999</xref>; <xref ref-type="bibr" rid="B8">Bers, 2000</xref>; <xref ref-type="bibr" rid="B9">Bers, 2002</xref>). In this study, we provide evidence for the first time of an enhancement in the reverse mode function of NCX in cardiomyocytes from infected mice (chronic&gt;acute&gt;early acute). The increase in [Ca<sup>2+</sup>]<sub>d</sub> mediated by NCX was not associated with membrane depolarization and was dependent on extracellular [Ca<sup>2+</sup>] and [Na<sup>+</sup>] in all cardiomyocytes. Therefore, changes in NCX could contribute to intracellular Ca<sup>2+</sup> overload, but could also contribute to the arrhythmogenesis observed in Chagas patients (<xref ref-type="bibr" rid="B38">Stein et al. 2018</xref>). The elevation of [Ca<sup>2+</sup>]<sub>d</sub> was prevented in cardiomyocytes from control and infected mice by removing extracellular Ca<sup>2+</sup> and reversed when Na<sup>+</sup> was reintroduced into the bath, except for cardiomyocytes from CP-infected mice, where the removal of Na<sup>+</sup> (partially or completely) produced irreversible contraction and cell death (40% in 65 mM [Na<sup>+</sup>]e and 82% in Na<sup>+</sup> free solution, respectively).</p>
<p>The mode in which NCX operates is dependent on the Na<sup>+</sup> and Ca<sup>2+</sup> gradients across the sarcolemma, as well as the membrane potential, following a driving force equal to <italic>E</italic>
<sub>m</sub> &#x2013; <italic>E</italic>
<sub>Na/Ca</sub> (where <italic>E</italic>
<sub>Na/Ca</sub>= 3E<sub>Na</sub> &#x2013;2 <italic>E</italic>
<sub>Ca</sub> with <italic>E</italic>
<sub>Na</sub> and <italic>E</italic>
<sub>Ca</sub> represent the equilibrium potentials of Na<sup>+</sup> and Ca<sup>2+</sup>, respectively) (<xref ref-type="bibr" rid="B13">Bers and Ginsburg, 2007</xref>). If the driving force for 3Na<sup>+</sup> is greater than 1Ca<sup>2+</sup> in the cell (3:1 Na<sup>+</sup>/Ca<sup>2+</sup> stoichiometry), the NCX will transport Na<sup>+</sup> into the cell and take Ca<sup>2+</sup> out (forward mode). On the other hand, if under another set of conditions (altered membrane potential, ionic gradients, or post-translational modifications), the driving force for 3Na<sup>+</sup> is less than that for 1Ca<sup>2+</sup> in the cell, then the electrochemical gradient of Ca<sup>2+</sup> will become the dominant inward driving force (reverse mode) (<xref ref-type="bibr" rid="B13">Bers and Ginsburg, 2007</xref>). The intracellular ionic changes in cardiomyocytes from infected mice modified the driving force (<italic>E</italic>
<sub>m</sub> &#x2212; <italic>E</italic>
<sub>Na/Ca</sub>) by 5 mV in cardiomyocytes from EAP-infected mice, 22 mV in cardiomyocytes from AP-infected mice, and 29 mV in cardiomyocytes from CP-infected mice.</p>
<p>KB-R7943 significantly reduced [Ca<sup>2+</sup>]<sub>d</sub> by 1.3 times in cardiomyocytes from EAP-infected mice, 1.7 times in AP-infected mice, and 1.8 times in CP-infected mice, suggesting that the elevation of [Ca<sup>2+</sup>]<sub>d</sub> observed in cardiomyocytes of Chagas infected mice was due in part to an influx of Ca<sup>2+</sup> mediated by NCX in its reverse mode. On the contrary, in cardiomyocytes from CONT mice, KB-R7943 did not modify [Ca<sup>2+</sup>]<sub>d</sub>, indicating that in healthy quiescent cardiomyocytes, NCX in its reverse mode does not contribute significantly to [Ca<sup>2+</sup>]<sub>d</sub>. Furthermore, KB-R7943 prevented the elevation of [Ca<sup>2+</sup>]<sub>d</sub> induced by Na<sup>+</sup> withdrawal in cardiomyocytes from CONT and cardiomyocytes from infected mice. The involvement of NCX in the pathophysiology of Chagas disease is consistent with the recent publication by Santos-Miranda et&#xa0;al. (<xref ref-type="bibr" rid="B35">Santos-Miranda et&#xa0;al., 2021</xref>), which found the contribution of NCX as a cellular arrhythmogenic substrate in isolated cardiomyocytes from infected mice with the Colombian strain of <italic>T</italic>. <italic>cruzi</italic>. However, the effect of KB-R7943 on [Ca<sup>2+</sup>]<sub>d</sub> must be considered with caution due to the lack of selectivity, since the NCX blocker also affects voltage-gated Na<sup>+</sup> and Ca<sup>2+</sup> channels, inward rectifying K<sup>+</sup> channels in cardiac cells (<xref ref-type="bibr" rid="B43">Watano et&#xa0;al., 1996</xref>).</p>
<p>YM-244769 is a potent and highly selective NCX blocker that up to 1 &#xb5;M (dose used in the present study) preferentially inhibits the reverse mode of NCX, with no effect on the forward mode (<xref ref-type="bibr" rid="B22">Iwamoto and Kita, 2006</xref>). YM-244769 significantly reduced [Ca<sup>2+</sup>]<sub>d</sub> by 1.3 times in cardiomyocytes from AP- and 1.4 times from CP-infected mice. YM-244769 did not significantly reduce [Ca<sup>2+</sup>]<sub>d</sub> in cardiomyocytes from CONT and EAP-infected mice, suggesting that the contribution of NCX to [Ca<sup>2+</sup>]<sub>d</sub> is negligible. The effect of YM-244769 on [Ca<sup>2+</sup>]<sub>d</sub> cardiomyocytes was small compared to KB-R7943, which is consistent with the fact that YM-244769 is a more specific NCX blocker and that KB-R7943 can act on other Ca<sup>2+</sup> entry pathways. Furthermore, YM-244769 blocked the observed elevation of [Ca<sup>2+</sup>]<sub>d</sub> caused by the Na<sup>+</sup> free solution in all cardiomyocytes. Together, these data strongly support the hypothesis that Ca<sup>2+</sup> entry mediated by the reverse NCX mode plays a significant role in [Ca<sup>2+</sup>]<sub>d</sub> dyshomeostasis observed in cardiomyocytes isolated from Chagas infected mice during acute and chronic stages of infection. The fact that KB-R7943 or YM-244769 did not normalize [Ca<sup>2+</sup>]<sub>d</sub> in cardiomyocytes from infected mice suggests the existence of additional Ca<sup>2+</sup> pathways that appear to be altered due to Chagas infection.</p>
<sec id="s4_1">
<title>Conclusions</title>
<p>These results provide, for the first time, evidence that NCX plays an important role in aberrant diastolic [Ca<sup>2+</sup>] observed in cardiomyocytes from infected mice (chronic&gt;acute&gt;early acute). These novel findings may open a new therapeutic approach to improve cardiac function in patients suffering from chronic Chagas cardiomyopathy because there is still no effective treatment. Unfortunately, Chagas cardiomyopathy remains largely ignored despite its medical and social relevance.</p>
</sec>
<sec id="s4_2">
<title>Study Limitations</title>
<p>Despite the novelty of this study, some limitations should be pointed out. We did not determine whether the elevation of [Na<sup>+</sup>]<sub>d</sub> in cardiomyocytes from infected mice could be related to an increased influx or decreased efflux of Na<sup>+</sup>. Furthermore, the expression of NCX and other proteins involved in intracellular Ca<sup>2+</sup> regulation were not studied.</p>
</sec>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by Care and Use Handbook of Laboratory Animals published by the US National Institute of Health (NIH publication No. 85-23, revised 1996) and approved by the Institutional Animal Care (IACUC) and Use Committees.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author Contributions</title>
<p>JRL: Designed research, performed the experiments, and analyzed the data; NL: Performed the experiments; JAA: Designed research; AM: Designed research, and analyzed the data. All authors contributed to manuscript revision, read, and approved the submitted version.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by the Florida Heart Research Foundation.</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The author thanks Dr. Jose O&#x2019;Daly for kindly giving us the <italic>T cruzi-</italic>infected mice.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abramochkin</surname> <given-names>D. V.</given-names>
</name>
<name>
<surname>Vornanen</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Inhibition of the Cardiac ATP-Dependent Potassium Current by KB-R7943</article-title>. <source>Comp. Biochem. Physiol. A Mol. Integr. Physiol.</source> <volume>175</volume>, <fpage>38</fpage>&#x2013;<lpage>45</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cbpa.2014.05.005</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akabas</surname> <given-names>M. H.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Na+/Ca2+ Exchange Inhibitors: Potential Drugs to Mitigate the Severity of Ischemic Injury</article-title>. <source>Mol. Pharmacol.</source> <volume>66</volume>, <fpage>8</fpage>&#x2013;<lpage>10</lpage>. doi: <pub-id pub-id-type="doi">10.1124/mol.104.000232.</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alarcon De Noya</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Diaz-Bello</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Colmenares</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Ruiz-Guevara</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Mauriello</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zavala-Jaspe</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Large Urban Outbreak of Orally Acquired Acute Chagas Disease at a School in Caracas, Venezuela</article-title>. <source>J. Infect. Dis.</source> <volume>201</volume>, <fpage>1308</fpage>&#x2013;<lpage>1315</lpage>. doi: <pub-id pub-id-type="doi">10.1086/651608</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almeida</surname> <given-names>B. C. S.</given-names>
</name>
<name>
<surname>Carmo</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Barbosa</surname> <given-names>M. P. T.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Ribeiro</surname> <given-names>A. L. P.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Association Between Microvolt T-Wave Alternans and Malignant Ventricular Arrhythmias in Chagas Disease</article-title>. <source>Arq. Bras. Cardiol.</source> <volume>110</volume>, <fpage>412</fpage>&#x2013;<lpage>417</lpage>. doi: <pub-id pub-id-type="doi">10.5935/abc.20180056</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aronsen</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Swift</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Sejersted</surname> <given-names>O. M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Cardiac Sodium Transport and Excitation-Contraction Coupling</article-title>. <source>J. Mol. Cell Cardiol.</source> <volume>61</volume>, <fpage>11</fpage>&#x2013;<lpage>19</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.yjmcc.2013.06.003</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benziger</surname> <given-names>C. P.</given-names>
</name>
<name>
<surname>Do Carmo</surname> <given-names>G. A. L.</given-names>
</name>
<name>
<surname>Ribeiro</surname> <given-names>A. L. P.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Chagas Cardiomyopathy: Clinical Presentation and Management in the Americas</article-title>. <source>Cardiol. Clin.</source> <volume>35</volume>, <fpage>31</fpage>&#x2013;<lpage>47</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ccl.2016.08.013</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bern</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Montgomery</surname> <given-names>S. P.</given-names>
</name>
<name>
<surname>Katz</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Caglioti</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Stramer</surname> <given-names>S. L.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Chagas Disease and the US Blood Supply</article-title>. <source>Curr. Opin. Infect. Dis.</source> <volume>21</volume>, <fpage>476</fpage>&#x2013;<lpage>482</lpage>. doi: <pub-id pub-id-type="doi">10.1097/QCO.0b013e32830ef5b6</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bers</surname> <given-names>D. M.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Calcium Fluxes Involved in Control of Cardiac Myocyte Contraction</article-title>. <source>Circ. Res.</source> <volume>87</volume>, <fpage>275</fpage>&#x2013;<lpage>281</lpage>. doi: <pub-id pub-id-type="doi">10.1161/01.RES.87.4.275</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bers</surname> <given-names>D. M.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Cardiac Excitation-Contraction Coupling</article-title>. <source>Nature</source> <volume>415</volume>, <fpage>198</fpage>&#x2013;<lpage>205</lpage>. doi: <pub-id pub-id-type="doi">10.1038/415198a</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bers</surname> <given-names>D. M.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Cardiac Sarcoplasmic Reticulum Calcium Leak: Basis and Roles in Cardiac Dysfunction</article-title>. <source>Annu. Rev. Physiol.</source> <volume>76</volume>, <fpage>107</fpage>&#x2013;<lpage>127</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev-physiol-020911-153308</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bers</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>Barry</surname> <given-names>W. H.</given-names>
</name>
<name>
<surname>Despa</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Intracellular Na+ Regulation in Cardiac Myocytes</article-title>. <source>Cardiovasc. Res.</source> <volume>57</volume>, <fpage>897</fpage>&#x2013;<lpage>912</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0008-6363(02)00656-9</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bers</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>Despa</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Cardiac Myocytes Ca2+ and Na+ Regulation in Normal and Failing Hearts</article-title>. <source>J. Pharmacol. Sci.</source> <volume>100</volume>, <fpage>315</fpage>&#x2013;<lpage>322</lpage>. doi: <pub-id pub-id-type="doi">10.1254/jphs.CPJ06001X</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bers</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>Ginsburg</surname> <given-names>K. S.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Na : Ca Stoichiometry and Cytosolic Ca-Dependent Activation of NCX in Intact Cardiomyocytes</article-title>. <source>Ann. N. Y. Acad. Sci.</source> <volume>1099</volume>, <fpage>326</fpage>&#x2013;<lpage>338</lpage>. doi: <pub-id pub-id-type="doi">10.1196/annals.1387.060</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blaustein</surname> <given-names>M. P.</given-names>
</name>
<name>
<surname>Lederer</surname> <given-names>W. J.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Sodium/calcium Exchange: Its Physiological Implications</article-title>. <source>Physiol. Rev.</source> <volume>79</volume>, <fpage>763</fpage>&#x2013;<lpage>854</lpage>. doi: <pub-id pub-id-type="doi">10.1152/physrev.1999.79.3.763</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Echavarria</surname> <given-names>N. G.</given-names>
</name>
<name>
<surname>Echeverria</surname> <given-names>L. E.</given-names>
</name>
<name>
<surname>Stewart</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Gallego</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Saldarriaga</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Chagas Disease: Chronic Chagas Cardiomyopathy</article-title>. <source>Curr. Probl. Cardiol.</source> <volume>46</volume>, <fpage>100507</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cpcardiol.2019.100507</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eltit</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Pessah</surname> <given-names>I. N.</given-names>
</name>
<name>
<surname>Allen</surname> <given-names>P. D.</given-names>
</name>
<name>
<surname>Lopez</surname> <given-names>J. R.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Nonspecific Sarcolemmal Cation Channels are Critical for the Pathogenesis of Malignant Hyperthermia</article-title>. <source>FASEB J.</source> <volume>27</volume>, <fpage>991</fpage>&#x2013;<lpage>1000</lpage>. doi: <pub-id pub-id-type="doi">10.1096/fj.12-218354</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Everts</surname> <given-names>M. E.</given-names>
</name>
<name>
<surname>Ording</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Hansen</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Nielsen</surname> <given-names>P. A.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Ca(2+)-ATPase and Na(+)-K(+)-ATPase Content in Skeletal Muscle From Malignant Hyperthermia Patients</article-title>. <source>Muscle Nerve</source> <volume>15</volume>, <fpage>162</fpage>&#x2013;<lpage>167</lpage>. doi: <pub-id pub-id-type="doi">10.1002/mus.880150206</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Freichel</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Berlin</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Schurger</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Mathar</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Bacmeister</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Medert</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). &#x201c;<article-title>TRP Channels in the Heart</article-title>,&#x201d; in <source>Neurobiology of TRP Channels</source>. Ed. <person-group person-group-type="editor">
<name>
<surname>Emir</surname> <given-names>T. L. R.</given-names>
</name>
</person-group>(<publisher-loc>Boca Raton (FL</publisher-loc>: <publisher-name>CRC Press/Taylor &amp; Francis</publisher-name>), <fpage>149</fpage>&#x2013;<lpage>185</lpage>.</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gray</surname> <given-names>R. P.</given-names>
</name>
<name>
<surname>Mcintyre</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Sheridan</surname> <given-names>D. S.</given-names>
</name>
<name>
<surname>Fry</surname> <given-names>C. H.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Intracellular Sodium and Contractile Function in Hypertrophied Human and Guinea-Pig Myocardium</article-title>. <source>Pflugers Arch.</source> <volume>442</volume>, <fpage>117</fpage>&#x2013;<lpage>123</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s004240000512</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Houser</surname> <given-names>S. R.</given-names>
</name>
<name>
<surname>Margulies</surname> <given-names>K. B.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Is Depressed Myocyte Contractility Centrally Involved in Heart Failure</article-title>? <source>Circ. Res.</source> <volume>92</volume>, <fpage>350</fpage>&#x2013;<lpage>358</lpage>.</citation>
</ref>
<ref id="B21">
<citation citation-type="other">
<article-title>Http://Www.Who.Int/Mediacentre/Factsheets/Fs340/En/</article-title>. (<year>2021</year>).</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwamoto</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kita</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>YM-244769, a Novel Na+/Ca2+ Exchange Inhibitor That Preferentially Inhibits NCX3, Efficiently Protects Against Hypoxia/Reoxygenation-Induced SH-SY5Y Neuronal Cell Damage</article-title>. <source>Mol. Pharmacol.</source> <volume>70</volume>, <fpage>2075</fpage>&#x2013;<lpage>2083</lpage>. doi: <pub-id pub-id-type="doi">10.1124/mol.106.028464</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwamoto</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Watano</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Shigekawa</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>A Novel Isothiourea Derivative Selectively Inhibits the Reverse Mode of Na+/Ca2+ Exchange in Cells Expressing NCX1</article-title>. <source>J. Biol. Chem.</source> <volume>271</volume>, <fpage>22391</fpage>&#x2013;<lpage>22397</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.271.37.22391</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Jain</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Isolation, Culture, and Functional Analysis of Adult Mouse Cardiomyocytes</article-title>. <source>Methods Mol. Med.</source> <volume>139</volume>, <fpage>251</fpage>&#x2013;<lpage>262</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-1-59745-571-8_16</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopez</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Alamo</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Caputo</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Dipolo</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Vergara</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>1983</year>). <article-title>Determination of Ionic Calcium in Frog Skeletal Muscle Fibers</article-title>. <source>Biophys. J.</source> <volume>43</volume>, <fpage>1</fpage>&#x2013;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0006-3495(83)84316-1</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopez</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Contreras</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Linares</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Allen</surname> <given-names>P. D.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Hypersensitivity of Malignant Hyperthermia-Susceptible Swine Skeletal Muscle to Caffeine is Mediated by High Resting Myoplasmic [Ca2+]</article-title>. <source>Anesthesiology</source> <volume>92</volume>, <fpage>1799</fpage>&#x2013;<lpage>1806</lpage>. doi: <pub-id pub-id-type="doi">10.1097/00000542-200006000-00040</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopez</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Espinosa</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Landazuru</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Linares</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Allen</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Mijares</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>[Dysfunction of Diastolic [Ca(2)(+)] in Cardiomyocytes Isolated From Chagasic Patients]</article-title>. <source>Rev. Esp. Cardiol.</source> <volume>64</volume>, <fpage>456</fpage>&#x2013;<lpage>462</lpage>.</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopez</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Kolster</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Adams</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Increased Constitutive Nitric Oxide Production by Whole Body Periodic Acceleration Ameliorates Alterations in Cardiomyocytes Associated With Utrophin/Dystrophin Deficiency</article-title>. <source>J. Mol. Cell Cardiol.</source> <volume>108</volume>, <fpage>149</fpage>&#x2013;<lpage>157</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.yjmcc.2017.06.004</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marban</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Rink</surname> <given-names>T. J.</given-names>
</name>
<name>
<surname>Tsien</surname> <given-names>R. W.</given-names>
</name>
<name>
<surname>Tsien</surname> <given-names>R. Y.</given-names>
</name>
</person-group> (<year>1980</year>). <article-title>Free Calcium in Heart Muscle at Rest and During Contraction Measured With Ca2+ -Sensitive Microelectrodes</article-title>. <source>Nature</source> <volume>286</volume>, <fpage>845</fpage>&#x2013;<lpage>850</lpage>. doi: <pub-id pub-id-type="doi">10.1038/286845a0</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mijares</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Altamirano</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Kolster</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Adams</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Lopez</surname> <given-names>J. R.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Age-Dependent Changes in Diastolic Ca(2+) and Na(+) Concentrations in Dystrophic Cardiomyopathy: Role of Ca(2+) Entry and IP3</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>452</volume>, <fpage>1054</fpage>&#x2013;<lpage>1059</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbrc.2014.09.045</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mijares</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Espinosa</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Adams</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Lopez</surname> <given-names>J. R.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Increases in [IP3]i Aggravates Diastolic [Ca2+] and Contractile Dysfunction in Chagas&#x2019; Human Cardiomyocytes</article-title>. <source>PLoS Negl. Trop. Dis.</source> <volume>14</volume>, <fpage>e0008162</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0008162</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x2019;Daly</surname> <given-names>J. A.</given-names>
</name> <name>
<surname>Simonis</surname> <given-names>S.</given-names>
</name> <name>
<surname>de Rolo</surname> <given-names>N.</given-names>
</name> <name>
<surname>Caballero</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>1984</year>). <article-title>Suppression of Humoral Immunity and Lymphocyte Responsiveness During Experimental Trypanosoma Cruzi Infections</article-title>. <source>Rev. Inst. Med. Trop.</source>  <volume>26</volume>(<issue>2</issue>):<fpage>67</fpage>&#x2013;<lpage>77</lpage>. doi: <pub-id pub-id-type="doi">10.1590/s0036-46651984000200001</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piacentino</surname> <given-names>V.</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Weber</surname> <given-names>C. R.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Weisser-Thomas</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Margulies</surname> <given-names>K. B.</given-names>
</name>
<name>
<surname>Bers</surname> <given-names>D. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2003</year>). <article-title>Cellular Basis of Abnormal Calcium Transients of Failing Human Ventricular Myocytes</article-title>. <source>Circ. Res.</source> <volume>92</volume>, <fpage>651</fpage>&#x2013;<lpage>658</lpage>. doi: <pub-id pub-id-type="doi">10.1161/01.RES.0000062469.83985.9B</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rassi</surname> <given-names>A.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Rassi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Marin-Neto</surname> <given-names>J. A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Chagas Disease</article-title>. <source>Lancet</source> <volume>375</volume>, <fpage>1388</fpage>&#x2013;<lpage>1402</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(10)60061-X</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santos-Miranda</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Joviano-Santos</surname> <given-names>J. V.</given-names>
</name>
<name>
<surname>Sarmento</surname> <given-names>J. O.</given-names>
</name>
<name>
<surname>Costa</surname> <given-names>A. D.</given-names>
</name>
<name>
<surname>Soares</surname> <given-names>A. T. C.</given-names>
</name>
<name>
<surname>Machado</surname> <given-names>F. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>A Novel Substrate for Arrhythmias in Chagas Disease</article-title>. <source>PloS Negl. Trop. Dis.</source> <volume>15</volume>, <fpage>e0009421</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0009421</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shannon</surname> <given-names>T. R.</given-names>
</name>
<name>
<surname>Pogwizd</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Bers</surname> <given-names>D. M.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Elevated Sarcoplasmic Reticulum Ca2+ Leak in Intact Ventricular Myocytes From Rabbits in Heart Failure</article-title>. <source>Circ. Res.</source> <volume>93</volume>, <fpage>592</fpage>&#x2013;<lpage>594</lpage>. doi: <pub-id pub-id-type="doi">10.1161/01.RES.0000093399.11734.B3</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname> <given-names>G. L.</given-names>
</name>
<name>
<surname>Eisner</surname> <given-names>D. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Calcium Buffering in the Heart in Health and Disease</article-title>. <source>Circulation</source> <volume>139</volume>, <fpage>2358</fpage>&#x2013;<lpage>2371</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.118.039329</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stein</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Migliavaca</surname> <given-names>C. B.</given-names>
</name>
<name>
<surname>Colpani</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Rosa</surname> <given-names>P. R.</given-names>
</name>
<name>
<surname>Sganzerla</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Giordani</surname> <given-names>N. E.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Amiodarone for arrhythmia in patients with Chagas disease: A systematic review and individual patient data meta-analysis</article-title>. <source>PLoS Negl Trop Dis</source> <volume>12</volume> (<issue>8</issue>), <page-range>e0006742</page-range>. doi: 10.1371/journal.pntd.0006742</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teixeira</surname> <given-names>A. R.</given-names>
</name>
<name>
<surname>Hecht</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Guimaro</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Sousa</surname> <given-names>A. O.</given-names>
</name>
<name>
<surname>Nitz</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Pathogenesis of Chagas&#x2019; Disease: Parasite Persistence and Autoimmunity</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>24</volume>, <fpage>592</fpage>&#x2013;<lpage>630</lpage>. doi: <pub-id pub-id-type="doi">10.1128/CMR.00063-10</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uryash</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Mijares</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Esteve</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Adams</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Lopez</surname> <given-names>J. R.</given-names>
</name>
</person-group> (<year>2021</year>a). <article-title>Cardioprotective Effect of Whole Body Periodic Acceleration in Dystrophic Phenotype Mdx Rodent</article-title>. <source>Front. Physiol.</source> <volume>12</volume>, <elocation-id>658042</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fphys.2021.658042</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uryash</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Mijares</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Flores</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Adams</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Lopez</surname> <given-names>J. R.</given-names>
</name>
</person-group> (<year>2021</year>b). <article-title>Effects of Naringin on Cardiomyocytes From a Rodent Model of Type 2 Diabetes</article-title>. <source>Front. Pharmacol.</source> <volume>12</volume>, <elocation-id>719268</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fphar.2021.719268</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Velasco</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Morillo</surname> <given-names>C. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Chagas Heart Disease: A Contemporary Review</article-title>. <source>J. Nucl. Cardiol.</source> <volume>27</volume>, <fpage>445</fpage>&#x2013;<lpage>451</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12350-018-1361-1</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watano</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kimura</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Morita</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Nakanishi</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>A Novel Antagonist, No. 7943, of the Na+/Ca2+ Exchange Current in Guinea-Pig Cardiac Ventricular Cells</article-title>. <source>Br. J. Pharmacol.</source> <volume>119</volume>, <fpage>555</fpage>&#x2013;<lpage>563</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1476-5381.1996.tb15708.x</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wussling</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Schenk</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Nilius</surname> <given-names>B.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>A Study of Dynamic Properties in Isolated Myocardial Cells by the Laser Diffraction Method</article-title>. <source>J. Mol. Cell Cardiol.</source> <volume>19</volume>, <fpage>897</fpage>&#x2013;<lpage>907</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0022-2828(87)80618-1</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>